John A. Smith

39.5k citations
254 papers · 12.6k · 9 hit papers · h-index 58

Impact in

    • Respiratory and Cough-Related Research
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Phonocardiography and Auscultation Techniques
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Gastroesophageal reflux and treatments

Papers in

    • Respiratory and Cough-Related Research 194
    • Chronic Obstructive Pulmonary Disease (COPD) Research 16
    • Phonocardiography and Auscultation Techniques 10
    • Cystic Fibrosis Research Advances 8
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
    • Asthma and respiratory diseases 15

John A. Smith

242 papers receiving 12.1k citations

John A. Smith's Hit Papers

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials 2022 · 239 citations
2390+6+12Years since publication200400600

Peers

John A. Smith
Comparison fields: 5 of 155
  • Pulmonary and Respiratory Medicine 8k
  • Gastroenterology 515
  • Physiology 287
  • Infectious Diseases 1.1k
  • Neurology 752
Replace Lorcan P. McGarvey with:
Lorcan P. McGarvey United Kingdom
Surinder Singh Birring United Kingdom
Geert M. Verleden Belgium
Bruce K. Rubin United States
You Shang China
Péter Jenő Hegyi Hungary
Johannes G. van der Hoeven Netherlands
Margaret Rosenfeld United States
Brent Anthony Senior United States
James J. Grady United States
John A. Smith relative to Lorcan P. McGarvey United Kingdom Lorcan P. McGarvey's profile →
Citations per field
00.5×1.5×1.8×
Lorcan P. McGarvey · 1×
Citations per year

Countries citing papers authored by John A. Smith

Since Specialization
Citations

This map shows the geographic impact of John A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Smith more than expected).

Fields of papers citing papers by John A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Smith. The network helps show where John A. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside John A. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. Smith Line = papers co-authored together John A. Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 254 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ERS guidelines on the diagnosis and treatment of chronic cough in adults and children
Hit paper breakdown →
2019608
2
ERS guidelines on the assessment of cough
Hit paper breakdown →
2007575
3
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Hit paper breakdown →
2021504
4
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
Hit paper breakdown →
2014415
5
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
6 2020355
7
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
Hit paper breakdown →
2022310
8
Expert opinion on the cough hypersensitivity syndrome in respiratory medicine
Hit paper breakdown →
2014303
9 2015282
10 2011267
11
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
Hit paper breakdown →
2022239
12 2014229
13 2014228
14
Cough hypersensitivity and chronic cough
Hit paper breakdown →
2022199
15 2020192
16 2010169
17 2016166
18 2014162
19 2007145
20 2014145

About John A. Smith

John A. Smith is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Infectious Diseases, Oncology and Gastroenterology, having authored 254 papers that have together received 12.6k indexed citations. Recurring topics across this work include Respiratory and Cough-Related Research (194 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Asthma and respiratory diseases (15 papers), Phonocardiography and Auscultation Techniques (10 papers), Cancer survivorship and care (8 papers), Cystic Fibrosis Research Advances (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Long-Term Effects of COVID-19 (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8k citations), Gastroenterology (515 citations), Physiology (287 citations), Infectious Diseases (1.1k citations) and Neurology (752 citations). John A. Smith has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ashley A. Woodcock, Lorcan P. McGarvey, Surinder Singh Birring, Alyn Hugh Morice, Peter V. Dicpinigaitis, Kimberley Holt, Angela Kelsall, Maria Gabriela Belvisi, Samantha Decalmer and Rachel Dockry. Their work appears in journals such as CHEST Journal, European Respiratory Journal, Journal of Allergy and Clinical Immunology, Thorax and ERJ Open Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact